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MicroScale Thermophoresis (MST) is a frequently used method for the quantitative characterization 
of intermolecular interactions with several advantages over other technologies. One of these is its 
capability to determine equilibrium constants in solution including complex biological matrices such as 
cell lysates. MST requires one binding partner to be fluorescent, which is typically achieved by labeling 
target proteins with a suitable fluorophore. Here, we present a near-native, site-specific in situ labeling 
strategy for MST experiments that enables reliable measurements in cell lysates and that has distinct 
advantages over routine covalent labeling techniques. To this end, we exploited the high-affinity 
interaction of tris-NTA with oligohistidine-tags, which are popular for purification, immobilization or 
detection of recombinant proteins. We used various DYE-tris-NTA conjugates to successfully label His-
tagged proteins that were either purified or a component of cell lysate. The RED-tris-NTA was identified 
as the optimal dye conjugate with a high affinity towards oligohistidine-tags, a high fluorescence 
signal and an optimal signal-to-noise ratio in MST binding experiments. Owing to its emission in the 
red region of the spectrum, it also enables reliable measurements in complex biological matrices such 
as cell lysates allowing a more physiologically realistic assessment and eliminating the need for protein 
purification.
Robust and reliable determination of the affinity between a target molecule and its interaction partner is a critical 
step in many areas of biological, biochemical and biomedical research and technology. For example, early phases 
of drug discovery include steps such as target identification and validation, hit discovery and lead optimization. 
During all of these steps, quantitative characterization of intermolecular interaction affinity is highly necessary to 
develop novel and effective drugs for therapeutic interventions1. MicroScale Thermophoresis (MST) is a versatile 
method to quantify binding affinities in solution that is increasingly applied for interaction analysis2,3. In this 
technique a variation in the fluorescence signal is detected, which is a result of a temperature gradient induced 
by an infrared laser4. The extent of the variation in the fluorescence signal correlates with the binding of a ligand 
to the fluorescent target5; thus, MST can be used to quantify the interaction and to determine equilibrium disso-
ciation constants (Kd). One notable advantage of MST over other routinely used methods for the quantification 
of molecular binding events, such as SPR and ITC, is that it can also be used for the determination of Kd values 
in complex sample matrices like cell lysate and serum4,6,7. Although MST measurements can be performed using 
intrinsic fluorescence of proteins, labeling of the target proteins with a suitable fluorophore is required when 
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using such complex samples. Unfortunately, in routine labeling techniques, the fluorophore is covalently attached 
to lysine residues using NHS- or to cysteine residues using maleimide chemistry. These labeling strategies are 
limited to purified proteins and cannot be applied in a mixture of several proteins or in complex biological matri-
ces such as cell lysate or blood serum8. The generation of purified protein can be challenging, time-consuming 
and expensive, sometimes not even applicable for the protein of interest9. Moreover, it is not possible to predict 
where the fluorophore will bind to the protein. Hence, covalent labeling of a protein with NHS or maleimide 
conjugated dye can lead to inhomogeneous protein-dye conjugates, some of which might even display desta-
bilization or loss of functionality10. Fortunately, in contrast, site-specific protein modification strategies allow 
structurally and stoichiometrically well-defined labeling with minimal perturbation of structural and functional 
integrity. Two things that have conquered modern life cell fluorescence imaging are the genetic fusion of fluores-
cent proteins and enzymes specifically engineered for posttranslational labeling11, but such relatively large tags 
are not always desired for quantitative interaction analysis. With the use of bioorthogonal conjugation reactions, 
labeling of non-purified proteins with high selectivity is possible, allowing rapid and cost-effective labeling12. 
Different site-specific labeling strategies have been proposed and applied, including co-translational introduction 
of unnatural or modified amino acids, or labeling via specific amino acid sequences, such as His-tag sequences 
and tetracysteine motifs8,13–17. Among these sequences, the His-tag is the most popular and widely used affinity 
tag for purification, immobilization or detection of proteins18–21.
The tris-NTA/His-tag system comprises one of the smallest high-affinity recognition elements known to 
date22. This interaction is based on the capacity of the histidine’s imidazole groups to form coordinative bonds 
with transition metal ions such as Ni(II). Chelators such as nitrilotriacetic acid (NTA)23 stably bind Ni(II) ions 
via three oxygen atoms and one nitrogen atom. The two remaining coordination sites of Ni(II) can each bind one 
histidine moiety of a His-tag (Fig. 1)8, yielding a molecular binding affinity of ~10 µM24. Tris-NTA is comprised 
of three NTA moieties coupled to a cyclic scaffold and thus can simultaneously bind six Histidine residues of 
a His6-tag, yielding subnanomolar binding affinity and a well-defined 1:1 stoichiometry24. Fast, stoichiometric 
binding of tris-NTA conjugates enabled in situ protein labeling of His-tagged proteins25–28 that was compatible 
with complex sample matrices including living cells22,25,29–31. These unique features make tris-NTA/oligohistidine 
interaction labeling an attractive candidate for quantitative protein interaction analysis by MST.
In this work, we present the application of tris-NTA-based labeling of His-tagged proteins for MST meas-
urements. For this purpose, tris-NTA was conjugated to three different fluorescent dyes: RED (NT647), GREEN 
(NT547) and BLUE (Oregon Green® 488), providing fluorophores from different spectral regions (Fig. 1A). The 
dyes NT647 and NT547 are MST-optimized dyes, which are commercially available as NHS or maleimide deriva-
tives for MST measurements. Our data highlights the versatility, robustness and superiority of the novel tris-NTA 
labeling approach for MST. Overall, the RED-tris-NTA conjugate (NT647-tris-NTA) arose as the optimal dye 
conjugate for this approach. This conjugate is characterized by a high affinity for His-tags, a high fluorescence 
signal and the best signal-to-noise ratio of all investigated DYE-tris-NTA conjugates. Owing to its red emission 
spectrum, it enables reliable measurements in complex biological matrices such as cell lysates, which display 
substantial autofluorescence in the blue and green part of the spectrum.
Results and Discussion
For the MST experiments in this study, the MST optimized dyes NT647 and NT547 were conjugated to tris-NTA. 
For the blue channel, the dye Oregon Green® 48825 was chosen. BLUE (OregonGreen® 488) is a derivate of flu-
orescein, the dyes RED (NT647) and GREEN (NT547) have distinct structures. The synthesis of DYE-tris-NTA 
constructs and the loading of the dyes with Ni(II) ions was performed according to previously described proto-
cols24,25. Concentrations of DYE-tris-NTA conjugates were determined photometrically and the dyes were stored 
at −20 °C until further use.
Figure 1. Labeling of His-tagged proteins via tris-NTA conjugates. (A) Chemical structure of the tris-NTA 
moiety conjugated to a fluorophore via a linker. Fluorophores are illustrated on the right: RED (NT647), 
GREEN (NT547) and BLUE (Oregon Green® 488). (B) Schematic representation of DYE-tris-NTA bound to 
a His-tagged protein. The conjugate is loaded with Ni(II) ions for the site-specific labeling of histidine-tagged 
proteins. Two remaining coordination sites of the NTA-complexed Ni(II) ions interact with histidine moieties 
of the protein’s His-tag.
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The affinity of DYE-tris-NTA for oligohistidine sequences. A high affinity of DYE-tris-NTA for olig-
ohistidines is a prerequisite for labeling of proteins for the quantification of intermolecular interactions with MST. 
We therefore determined the affinity between the DYE-tris-NTA and two oligohistidine sequences: a His6-peptide 
and the MAP kinase p38 alpha (p38α) fused to an N-terminal His6-tag. As expected24, BLUE-, GREEN- and 
RED-tris-NTA displayed high affinity for the His6-peptide (6.7 ± 4.1 nM, 4.4 ± 3.7 nM and 3.8 ± 0.5 nM, respec-
tively, Fig. 2). Comparable affinities were measured for the His6-tag fused to the N-terminus of p38α, yield-
ing Kd values of 2.7 ± 1.7 nM for BLUE-tris-NTA, 6.3 ± 1.7 nM for GREEN-tris-NTA and 2.1 ± 0.8 nM for 
RED-tris-NTA, respectively (Fig. 3). These binding affinities are in excellent agreement with previously pub-
lished Kd values of tris-NTA/His-tag interaction24. Slight differences in the Kd values between His6-peptide and 
Figure 2. MST interaction analysis of His6-peptide against different tris-NTA fluorophores. (A) Schematic 
representation of DYE-tris-NTA interaction with His6-peptide. (B,C,D) MST traces (top) and dose-response 
curves (bottom) of His6-peptide titrated against tris-NTA conjugated dyes. (B) BLUE-tris-NTA (C) GREEN-
tris-NTA and (D) RED-tris-NTA. 25 nM of DYE-tris-NTA was added to a 16-step serial dilution of His6-
peptide. Mean values of three independent experiments are shown. Error bars indicate the standard deviation. 
MST experiments were carried out at medium MST power at 25 °C. LED power was set to 20% (B), 100% 
(C) and 40% (D). The resulting dose-response curves were fitted to a one-site binding model to extract 
Kd values; the standard deviation was calculated using the Kd values from each independent experiment. 
Fnorm = normalized fluorescence.
Figure 3. MST analysis of tris-NTA fluorophores interacting with p38α. (A) Schematic representation of 
tris-NTA-fluorophores and p38α (PDB: 1A9U). (B,C) Dose-response curves for BLUE-tris-NTA and GREEN-
tris-NTA against His6-p38α (black) and p38α (grey) (n = 2). (D) MST traces (top) and dose-response curve 
(bottom) of His6-p38α (black) and p38α (grey) towards RED-tris-NTA (n = 3). All resulting dose-response 
curves were fitted to a one-site binding model to obtain Kd values. Error bars indicate the standard deviation. 
MST experiments were performed at a LED power of 60% (A), 100% (C) and 40% (D) and at medium MST 
power. Fnorm = normalized fluorescence.
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His6-p38α can be explained with differences in the accessibility and the electrostatics due to structural character-
istics of the protein and the fluorophores.
Notably, the binding of BLUE-tris-NTA and GREEN-tris-NTA to His6-p38α resulted in a ligand-induced 
fluorescence change. To exclude the possibility of nonspecific interactions between these dyes and the ligand, we 
performed an EDTA/His6-peptide (ECP) test, which quantifies ligand-induced fluorescence changes while using 
DYE-tris-NTA labeling. It consists of two subtests that must be performed to unambiguously distinguish between 
fluorescence changes caused by interaction and those caused by non-specific effects. In the case of His-tag labeling 
non-specific effects can be caused by interaction of a ligand with the His-tag bound tris-NTA dye (His6-peptide 
test) or by ligand-induced aggregation or adsorption to labware (EDTA test). Nonspecific interaction between 
BLUE-tris-NTA and GREEN-tris-NTA and the ligand was excluded based on this test (Supplementary Figure S1). 
Hence, the fluorescence signal was used for evaluation of binding data (Fig. 3B and C). In addition, for the p38α 
protein lacking His6-tag no binding was detected with any DYE-tris-NTA (Fig. 3).
Stability of DYE-tris-NTA binding to His-tags. The Ni(II)/His-tag interaction is reversible upon addi-
tion of competitor substances such as histidine or imidazole. This feature is useful in some contexts, since it 
enables removal of immobilized molecules from microarray surfaces or elution of purified proteins from 
column-chromatography32,33. However, in the context of protein labeling for binding studies, disruption of the 
Ni(II)/His-tag interaction should be avoided, since it results in dissociation of the dye. To investigate poten-
tially interfering buffer components, we systematically screened a set of common additives with respect to their 
effects on tris-NTA labeling. To this end, His6-peptide was titrated against RED-tris-NTA, while varying the 
concentration of different additives in the assay buffer PBST. These additives are listed in Supplementary Table S1, 
together with the highest concentration tested and their maximum tolerable concentration for the tris-NTA labe-
ling approach. The maximum allowed assay concentration was defined as the highest concentration that did not 
alter the Kd value, whereas a slight decrease in the signal-to-noise ratio or in the binding amplitude was tolerated. 
In general, chelating agents such as ethylenediaminetetraacetic acid (EDTA) and ethylenglycol-bis(aminoethy-
lether) (EGTA) or the ionic detergent sodium dodecyl sulfate (SDS) should be avoided. In addition, Tris-based 
assay buffers are known to exhibit some ion-complexing capacities34,35, therefore a caution and additional pretests 
are recommended when used for DYE-tris-NTA labeling. The use of divalent metal ions as Zn(II), Co(II) and 
Ni(II) as additives is not recommended, because they interfere with the labeling. Bovine serum albumin (BSA) 
and various proteins without His-tag showed no interference at any of the tested concentrations. In general, 
the tris-NTA labeling method turned out to be highly robust toward buffer additives, even regarding competi-
tor substances such as imidazole or histidine. Here, only concentrations higher than 1 mM showed interference 
with the labeling reaction. Additionally, reducing agents such as tris(2-carboxyethyl)phosphine hydrochloride 
(TCEP) and dithiothreitol (DDT) can be used in the labeling buffer as well. This insensitivity and robustness of 
DYE-tris-NTA thus mostly allows labeling of proteins directly in their storage buffers, without the need for buffer 
exchange.
Determination of ligand binding affinity using DYE-tris-NTA labeled target proteins. A high 
affinity of DYE-tris-NTA for His-tags is a prerequisite for efficient stoichiometric labeling of His-tagged proteins 
for MST measurements. Because of all our DYE-tris-NTA candidates showed an affinity in the low nM range, we 
proceeded with the determination of ligand binding affinity using DYE-tris-NTA labeled target proteins. For a 
protein-small molecule interaction, His6-p38α was labeled with all three DYE-tris-NTA candidates separately. To 
ensure that virtually all dye is bound to the protein, we labeled the protein at a ratio of 1:2 (dye:protein) and incu-
bated the protein/dye mixture for 30 min at room temperature to enable complete binding of the DYE-tris-NTA 
to the protein. As evident from the experiment depicted in Fig. 3, when we use 25 nm of DYE-tris-NTA, the 
binding of the DYE-tris-NTA reaches the saturation at the concentration of p38α of about 50 nM. With further 
increasing of the protein concentration, no additional increase in the binding of the dye is observed. This means 
that all dye is bound to the protein at a ratio of about 1:2. Based on this finding, efficient labeling was achieved and 
no separation of unbound dye was required. We proceeded immediately to the next step and added the labeled 
target protein to a dilution series of PD169316, a known selective inhibitor of p38α36,37. The ligand AGI-5198 
(IDH-C35), a potent inhibitor of isocitrate dehydrogenase 1, served as a negative control. For PD169316 we meas-
ured Kd values of 16.7 ± 1.2 nM, 35 ± 5 nM and 24 ± 9 nM for BLUE-, GREEN- and RED tris-NTA, respectively, 
which is in accordance with published values38 (Fig. 4).
As a second example, the interaction between maltose-binding-protein (MBP) and MBP-binding protein 
was analyzed. This 15 kD VHH binds MBP of E. coli with high affinity (ChromoTek GmbH, unpublished data). 
For MST affinity analysis, His6-tagged MBP-binding protein was labeled with all three DYE-tris-NTA conju-
gates separately and added to a serial dilution of MBP in PBST buffer. The Kd values measured were 6 ± 2 nM 
for BLUE-tris-NTA, 5 ± 4 nM for GREEN-tris-NTA and 7 ± 1 nM for RED-tris-NTA (Fig. 5). No binding was 
detected for labeled His6-peptide against titrated MBP, which underscores the high specificity of the MBP-binding 
protein for its ligand MBP. Among all DYE-tris-NTA candidates, RED-tris-NTA showed the best signal-to-noise 
ratio.
As is evident from Figs 3 to 5, differences in MST binding curve direction can be observed between the three 
DYE-tris-NTA candidates. For RED-tris-NTA and GREEN-tris-NTA, the unbound state of the protein exhib-
its the smallest changes in fluorescence; while for BLUE-tris-NTA, the bound state of the protein exhibits the 
smallest changes in the fluorescence. As mentioned previously, RED- and GREEN-tris-NTA are highly similar 
regarding their chemical structures, whereas BLUE-tris-NTA belongs to a different family of dyes. These molec-
ular properties likely result in different MST signals of labeled proteins in the unbound and bound state and thus 
reverse the direction of the sigmoidal binding curve.
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Determination of ligand binding affinity by labeling of His6-tagged target proteins in crude cell 
lysate. The determination of ligand binding affinity directly in complex sample matrices like crude cell lysate, 
cell-free expression systems and blood serum offers several advantages. This approach is not only faster and more 
cost-effective, but it also enables studies with proteins in their natural environment. As the degree of autofluores-
cence from cell lysate components is higher for green and blue spectral regions, we decided to use RED-tris-NTA 
for all ligand binding studies in cell lysates.
As a first example, p38α-mNeonGreen-His6 and mNeonGreen-His6 were both expressed in mammalian cells 
for direct labeling in cell lysate using RED-tris-NTA. Labeling products were then used to quantify the interac-
tion between p38α and SB203580. Thereby, mNeonGreen-His6 served as a negative control to verify the high 
specific binding of the small inhibitory compound to p38α. Further, the same interaction was quantified using 
mNeonGreen-His6-p38α as a target. Fluorescent proteins like mNeonGreen can be used as a fluorescent label for 
MST affinity analysis, which is performed directly in the cell lysate.
Figure 4. The interaction of p38α protein with small molecule inhibitors. MST traces (top) and dose-response-
curves (bottom) for labeled His6-p38α (BLUE-tris-NTA (B), GREEN-tris-NTA (C) and RED-tris-NTA (A)) 
against PD169316 (black) or IDH-C35 (grey). The resulting dose-response curves were fitted to a one-site 
binding model for Kd determination. All measurements were done in triplicates, error bars indicate the standard 
deviation. MST experiments were performed at high MST power and LED power of 60%,100% and 20% (from 
left to right). Fnorm = normalized fluorescence.
Figure 5. MST traces (top) and dose-response curves (bottom) of MBP towards BLUE-tris-NTA-MBP-binding 
protein (A), GREEN-tris-NTA-MBP-binding protein (B) and RED-tris-NTA-MBP-binding protein (C). The 
resulting dose-response curves were fitted to a one-site binding model to extract Kd values. All experiments 
were done in triplicates. Error bars indicate the standard deviation. MST experiments were performed at a LED 
power of 60% (A), 100% (B) and 40% (C) and at high MST power. Fnorm = normalized fluorescence.
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To first determine the optimal dye-to-protein ratio for this labeling approach, first the concentration of p38α 
in cell lysate was experimentally determined. Therefore, cell lysate was titrated against a constant concentration 
of RED-tris-NTA and MST was carried out. Knowing the Kd value of this interaction from the experiments 
described above (Fig. 3), the concentration of p38α in the cell lysate could be determined as described in the 
Method section. Assuming the expression level of mNeonGreen-His6 to be like that of mNeonGreen-His6-p38α, 
the same amount of fluorophore was added to cell lysate containing mNeonGreen-His6, which served as negative 
control. For the MST experiment, a serial dilution of SB203580 was prepared using PBST buffer and a constant 
amount of labeled p38α-mNeonGreen-His6 or labeled mNeonGreen-His6 was added to all dilution steps. Only 
cell lysate containing labeled p38α showed clear binding towards SB203580 with a Kd of 116 ± 0.84 nM, while no 
binding could be detected for the p38α-free measurement (Fig. 6A). When mNeonGreen-His6-p38α was used 
as the target, much higher noise level was observed at simultaneously smaller binding amplitude (Fig. 6B), which 
consequently resulted in a less reliable fit of the Kd value. Nevertheless, the estimated Kd of 56.8 ± 39 nM is com-
parable to the Kd determined with RED-tris-NTA labeled His6-p38α.
In the next experimental settings, we compared the MST measurements, in which either the purified protein 
or the protein in crude cell lysate was employed. Therefore, we used two proteins His6-pUL53 and pUL50, which 
form the core nuclear egress complex of human cytomegalovirus (HCMV)39. First we tested the binding affinity 
of RED-tris-NTA towards His6-pUL53 in E. coli cell lysate. For this purpose, protein-containing cell lysate was 
titrated and a constant amount of RED-tris-NTA was added to all dilution steps. Figure 7A shows the MST data 
for this interaction. The binding curve was further used to roughly estimate the concentration of His6-pUL53 in 
the cell lysate to further determine the optimal dye concentration for protein labeling. To quantify the interac-
tion between RED-tris-NTA labeled His6-pUL53 and pUL50, a serial dilution of the ligand was prepared using 
PBST buffer and a constant amount of labeled target protein was added to all dilution steps. As a control, pUL53 
was purified after expression in E. coli, labeled using RED-tris-NTA and added to a serial dilution of pUL50 
in HEPES buffer. Kd values of 1.2 ± 0.5 μM for the purified protein and 1.8 ± 0.2 μM for the measurements in 
crude cell lysate were obtained. These two values are in good agreement with each other and differ only slightly 
from the Kd value reported by Sam et al. using ITC measurements (Kd = 0.29 µM)40. The likely reason for this is 
that formation of the heterodimeric His6-pUL53:pUL50 complex is preceded by the dissociation of homodi-
meric His6-pUL53 into monomers. Hence, the Kd values measured here represent apparent affinities, and are thus 
concentration-dependent.
These two examples highlight the versatility, specificity and robustness of the RED-tris-NTA/His-tag system 
for the use in complex sample matrices such as cell lysate. Measured Kd values were in good agreement with pub-
lished values and undistinguishable from the binding affinities determined in MST experiments using purified 
proteins.
Figure 6. MST traces (top) and dose-response curve (bottom) of the interaction analysis of p38α against 
SB203580 in HeLa cell lysate in two different detection channels. (A) His6-p38α was labeled in HeLa cell 
lysate to determine its binding affinity toward SB203580 (black, n = 3). MST experiments were carried out at 
100% LED and high MST power. mNeonGreen-His6 served as negative control and did not yield a binding 
curve (grey, n = 2). Here, 20% LED and high MST power were used. B) p38α-mNeonGreen-His6 against 
SB203580 (n = 2). Experiments were carried out at 20% LED and high MST power. The extracted Kd value was 
56.8 ± 39 nM. Fnorm = normalized fluorescence.
www.nature.com/scientificreports/
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Conclusions
MicroScale Thermophoresis (MST) is routinely used for the quantification of molecular binding events and 
can even be used with complex biological matrices like cell lysate and serum. With the intention to develop a 
near-native labeling strategy for MST measurements, we exploited the tris-NTA/His-tag system, which comprises 
one of the smallest high-affinity recognition elements known to date. The conjugation of BLUE (OregonGreen® 
488), GREEN (NT547) and RED (NT647) to tris-NTA resulted in fluorescence probes with high affinity and 
selectivity for oligohistidine tags, an ideal tool for site-selective labeling of proteins for quantitative characteriza-
tion of intermolecular interactions by MST. All investigated DYE-tris-NTA conjugates displayed a high affinity 
for oligohistidine-tags. The RED-tris-NTA conjugate was identified as the optimal dye conjugate, requiring only 
low LED power and yielding the best signal-to-noise ratios. This conjugate was also successfully used for the labe-
ling of oligohistidine-tagged proteins in crude cell lysate, which allowed the determination of binding affinity for 
a binding partner directly in lysate. As outlined in this study, the compatibility of RED-tris-NTA with complex 
sample matrices such as cell lysate has two major benefits: firstly, it permits the study of biomolecular interactions 
in near-native environment, allowing a more physiologically realistic assessment. And secondly, it may eliminate 
the need for protein purification for many MST assay setups, enabling shorter workflows and easier investigation 
of difficult-to-purify proteins. Combined with its high specificity for His-tags, this labeling strategy offers numer-
ous advantages for protein labeling.
Materials and Methods
Materials. Chemicals for the synthesis of tris-NTA conjugated fluorophores and small molecule inhibitors 
were purchased from Sigma-Aldrich: dimethylformamide (DMF; Cat. No. 227056), ethyldiisopropylamine 
(EDIPA; Cat. No. 03440), nickel(II) chloride (NiCl2; Cat No. 339350), PD169316 (Cat. No. P9248), AGI-5198 
(IDH-C35; Cat. No. SML0839) and SB203590 (Cat. No. S8307). Fluorophores (NHS ester) were obtained from 
NanoTemper Technologies GmbH (NT647; Cat. No. MO-L001 and NT547; MO-L002) or from ThermoFisher 
Scientific (Oregon Green® 488; Cat. No. O6149). Proteins were obtained from CRELUX GmbH (p38α), from 
ChromoTek GmbH (MBP-binding protein; Cat. No. mbt-250) or from antibodies-online GmbH (MBP; Cat. No. 
MBP0801). His6-peptide was purchased from APExBIO (Cat. No. A6006).
All measurements were carried out on a Monolith NT.115 device (NanoTemper Technologies GmbH), 
equipped with a RED/GREEN or BLUE detection channel.
Figure 7. MST affinity analysis of RED-tris-NTA toward His6-pUL53 containing cell lysate and of labeled 
pUL53 toward pUL50 in E. coli lysate. MST traces (top) and dose-response curves (bottom) for His6-pUL53 
against RED-tris-NTA (A) and RED-tris-NTA labeled pUL53 against pUL50 (B) (n = 3). (A) The interaction 
between RED-tris-NTA and His6-pUL53 was measured directly in E. coli lysate at LED 40% and high MST 
power. (B) MST traces of His6-pUL53 RED-tris-NTA in E. coli lysate (top) and comparison of the binding 
affinity of pUL50 toward labeled His6-pUL53 measured either with purified His6-pUL53 (black) or with His6-
pUL53 in crude lysate (red) (bottom). Measurements were performed at 40% LED and medium MST power. 
Fnorm = normalized fluorescence.
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Synthesis and preparation of tris-NTA conjugated fluorophores. OregonGreen® 488-tris-NTA 
was prepared as previously published25. NT647 and NT547-tris-NTA conjugates were synthesized and charac-
terized as following: tris-NTA modified by an aminocaproic acid (tris-NTA, MW: 1048 g/mol) was synthesized 
as previously described24 to yield tris-NTA-ACA. 5.9 mg tris-NTA-ACA was dissolved in 100 µl dry DMF, fol-
lowed by addition of 12 µl EDIPA. 3.0 mg NHS ester of fluorophores was separately dissolved in 100 µl dry DMF. 
Solutions were mixed and stirred overnight (20 h) at room temperature under the protection of N2 atmosphere 
in darkness. After addition of 100 µl H2O, the reaction mixture was continuously stirred for 1 h to quench unre-
acted NHS groups. The mixture was diluted in 20 ml of 0.1% TFA/water and was loaded on a C18 reverse phase 
HPLC column (Vydac 218TP, 250 × 4.6 mm) for purification using a 0–70% acetonitrile gradient in 0.1% TFA/
water (1/6 of the reaction per run). The DYE-tris-NTA conjugates were eluted at ~45% acetonitrile. The purified 
DYE-tris-NTA fractions of each dye were pooled together and lyophilized as blueish, orange or pink powder and 
stored at −20 °C. Obtained products were verified by the MS-ESI analyses.
For the nickel loading, the obtained DYE-tris-NTA- were dissolved in 20–50 mL of 10 mM HEPES buffer pH 
7.5 to a final concentration of 0.1 mM or less. NiCl2, in a final concentration of 5 mM was added to this solution 
for loading Ni(II) ions on the NTA groups. After 15 min, the solution was loaded onto a 1 ml anion-exchange 
column (Hitrap Q, GE Healthcare) and eluted with a gradient of 0–600 mM sodium chloride in 10 mM HEPES 
buffer, pH 7.5. The Ni(II)-loaded tris-NTA-fluorophores were eluted at ~300 mM sodium chloride. For each dye, 
the fractions from the elution peak were combined, and the concentrations were determined photometrically at 
647 nm and 547 nm using an extinction coefficient of 250000 M−1cm−1 and 150000 M−1cm−1, respectively. The 
final products were aliquoted in black Eppendorf tubes and stored at −20 °C.
Determination of DYE-tris-NTA binding affinity for oligohistidine tags. His6-peptide or His6-p38α 
(expression construct CJA3) were diluted in PBST buffer to a final concentration of 10 µM and 2 µM, respectively. 
This solution was used for a 16-step serial dilution in PBST buffer (137 mM NaCl, 2.5 mM KCl, 10 mM Na2HPO4, 
2 mM KH2PO4, pH 7.4, 0.05% Tween-20) with 10 µl volume in each sample. Next, 10 µl of 50 nM dye, dissolved in 
PBST buffer, was added to all vials of the serial dilution. Samples were mixed by pipetting up and down and reac-
tion was incubated for 30 min at room temperature in the dark, before samples were loaded into Monolith NT.115 
Capillaries. Samples were then transferred into the Monolith NT.115 device and MST experiments were carried 
out at 40% (RED)/20% (BLUE)/100% (GREEN) LED and medium MST power for the His6-peptide measure-
ments and at 40% (RED)/60% (BLUE)/100% (GREEN) LED and medium MST power for the His6-p38α studies.
Labeling and MST measurements of purified His6-tagged proteins. Proteins (His6-p38α and 
His6-MBP-binding protein were diluted to 200 nM in PBST buffer (137 mM NaCl, 2.5 mM KCl, 10 mM Na2HPO4, 
2 mM KH2PO4, pH 7.4, 0.05% Tween-20). Tris-NTA dyes were diluted in PBST buffer to a final concentration 
of 100 nM. 100 µl of protein was then mixed with 100 µl of each dye separately and the reaction mixtures were 
incubated for 30 min at room temperature in the dark.
Ligand dilution series: Small molecule inhibitors were stored in 100% DMSO at −20 °C. For the dilution 
series, a 10 µM solution of PD169316 or of AGI-5198 (IDH-C35) was prepared using PBST buffer (2% final 
DMSO concentration). This stock solution was used for the preparation of a 16-step serial dilution in PBST 
buffer, supplemented with 2% DMSO, with a final volume of 10 µl in each vial of the dilution series. For the 
protein-protein interaction, 5 µM of MBP diluted in PBST buffer was used as the highest ligand concentration of 
the 16-step dilution series, with a final volume of 10 µl in each reaction tube.
Then 10 µl of 100 nM RED/GREEN or BLUE labeled protein (p38α or MBP-binding protein) was added to all 
16 vials and samples were mixed by pipetting up and down. Reactions were incubated for 30 min at room tem-
perature away from light and then loaded into Monolith NT.115 Capillaries. Using the Monolith NT.115 device, 
MST was carried out at 20% (RED)/60% (BLUE)/100% (GREEN) LED and high MST power for p38α, and at 40% 
(RED)/60% (BLUE)/100% (GREEN) LED and high MST power for MBP-binding protein.
Labeling and MST measurements of oligohistidine-tagged proteins in crude cell lysate. p38α 
against SB203580. The p38α protein sequence was obtained through reverse transcription on mRNA from A549 
cells. Using In-Fusion Cloning technology (Takara Bio USA, Inc.) this p38α coding sequence was cloned in a 
pcDNA3.1 mammalian expression vector behind a CMV promotor and separated from the mNeongreen-His6-tag 
by the linker sequence ESGSGS. A pcDNA3.1 vector coding for only mNeongreen-His6 was used as a control. 
These two plasmids expressing mNeongreen-His6 with and without the p38α sequence were transfected into 
3*10^6 HeLa cells using separate T-75 flasks. Cells were grown for 24 h reaching approximately 10*10^6 cells. 
Cells were pelleted by centrifugation and resuspended in 1 ml PBST buffer (137 mM NaCl, 2.5 mM KCl, 10 mM 
Na2HPO4, 2 mM KH2PO4, pH 7.4, 0.05% Tween-20), supplemented with protease inhibitors. At this step, the cells 
were disrupted using a Dounce homogenizer and centrifuged again at 14 000 × g for 30 min at 4 °C to remove cell 
debris. Obtained supernatant was diluted 1:10 in PBST, supplemented with protease inhibitors.
Concentration of His6-tagged protein in cell lysate was determined by the MST experiment as described in the 
Supplemental information, Fig. S2. The labeling of p38α-mNeonGreen-His6 and mNeonGreen-His6 in HeLa cells 
was carried out by mixing 100 µl of about 100 nM p38α-mNeonGreen-His6 or mNeonGreen-His6 with 100 µl of 
100 nM NT647-tris-NTA dye in PBST buffer. Reaction mixture was incubated for 30 min at room temperature.
For the MST binding experiment, the stock solution of SB203580 (stored at 2.65 mM in 100% DMSO at −20 °C) 
was diluted 1:50 in PBST, reaching a concentration of 53 µM with 2% DMSO. This solution was used for a 1:1 serial 
dilution using 16 dilution steps and a final volume of 10 µl for each point of the dilution series. Afterwards 10 µl cell 
lysate was added to all steps of the dilution series, giving a final ligand concentration of 26.5 µM with 1% DMSO. 
Reaction was incubated for 30 min at room temperature, centrifuged at 14 000 g for 10 min at 4 °C and loaded into 
Monolith NT.115 MST Premium Capillaries. MST experiment was carried out using 100% or 20% LED power for 
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the p38α containing sample and for the negative control, respectively, and high MST power for the NT.115 RED 
instrument. For the NT.115 blue device 20% LED and high MST power was used.
pUL53 against pUL50. For protein expression, a plasmid encoding a His6-tagged protein variant of pUL53 (res-
idues 50 to 292 of human cytomegalovirus ORF-UL53 1-376)39 was transformed into BL21(DE3) cells and grown 
in LB medium in the presence of 100 mg/ml ampicillin and 32 mg/ml kanamycin at 33 °C until OD600 of 0.4. 
When the required OD was reached, 0.25 mM isopropyl -D-thiogalactopyranoside was added to induce protein 
expression. The culture was further incubated overnight at 20 °C. Cells were harvested by centrifugation, dis-
rupted by sonication and resuspended in lysis buffer (50 mM phosphate buffer, pH 7.4, 300 mM NaCl) containing 
protease inhibitors, lysozyme, and DNase.
For affinity determination of His6-pUL35 against RED-tris-NTA, pUL53-containing cell lysate was diluted 
1:10 in PBST buffer and a 16-step serial dilution was prepared. RED-tris-NTA was then added to all dilution steps 
with a final concentration of 25 nM. Samples were incubated for 30 min at room temperature in the dark, before 
they were loaded into Monolith NT.115 MST Premium Capillaries and loaded into the Monolith NT.115 device. 
MST experiment was carried out at 40% LED and high MST power.
Labeling of His6-pUL53 in E. coli lysate was carried out by diluting the lysate 1:10 in PBS-T buffer and adding 
RED-tris-NTA dye at a final concentration of 50 nM. The mixture was incubated for 30 min at room temperature. 
For the labeling of purified His6-pUL53, the protein was first purified from the E. coli cell lysate via a Ni-NTA 
affinity chromatography followed by a size exclusion chromatography step. After purification, His6-pUL53 was 
labeled by mixing100 µl of a 200 nM protein solution with 100 µl of 50 nM RED-tris-NTA using PBST as reaction 
buffer. Mixture was incubated for 30 min at room temperature in the dark.
For affinity analysis of purified and non-purified RED-tris-NTA His6-pUL53 against pUL50 (obtained as pre-
viously described)39, HEPES buffer (200 mM, 25 mM HEPES, 1 mM TCEP, pH 8.0) was used. The highest ligand 
concentration in the 16-step serial dilution series was 1 µM, with 10 µl volume in each titration step. 10 µl labeled 
protein was then added to all dilutions at a final concentration of 100 nM. Samples were mixed and loaded in 
Monolith NT.115 MST Premium Capillaries. MST experiments were carried out at 40% LED and 60% MST 
power.
Data acquisition and analysis. The data were acquired with MO.Control 1.5.3 (NanoTemper Technologies 
GmbH). Recorded data were analyzed with MO.Affinity Analysis 2.2.7 (NanoTemper Technologies GmbH). The 
MST on-time yielding the highest signal-to-noise ratio was used for the Kd determination. The data were fitted 
using a Kd fit model that describes a molecular interaction with a 1:1 stoichiometry according to the law of mass 
action. The Kd is estimated by fitting the Eq. 1:
= + − ×
+ + − + + −
f c Unbound Bound Unbound
c c K c c K cc
c
( ) ( )
( ) 4
2 (1)
target d target d target
target
2
Where f(c) is the fraction bound at a given ligand concentration c; Unbound is the Fnorm signal of the target; 
Bound is the Fnorm signal of the complex; Kd is the dissociation constant or binding affinity; and the ctarget is the 
final concentration of target in the assay.
Data availability. The datasets generated during and/or analyzed during the current study are available from 
the corresponding author on reasonable request. The structural information on NT647 and NT547 is proprietary 
and cannot be disclosed.
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